Combination therapy for chronic hepatitis C
- PMID: 10363199
Combination therapy for chronic hepatitis C
Comment on
-
Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.Ital J Gastroenterol Hepatol. 1999 Mar;31(2):130-4. Ital J Gastroenterol Hepatol. 1999. PMID: 10363198 Clinical Trial.
Similar articles
-
Amantadine in the treatment of patients with chronic hepatitis C.Ital J Gastroenterol Hepatol. 1998 Dec;30(6):614-5. Ital J Gastroenterol Hepatol. 1998. PMID: 10076784 No abstract available.
-
Role of amantadine and other adjuvant therapies in the treatment of hepatitis C.Semin Liver Dis. 2004;24 Suppl 2:89-95. doi: 10.1055/s-2004-832933. Semin Liver Dis. 2004. PMID: 15346251 Review.
-
Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/or ribavirin.Clin Infect Dis. 2001 Mar 1;32(5):830-1. doi: 10.1086/319220. Epub 2001 Feb 28. Clin Infect Dis. 2001. PMID: 11229855 Clinical Trial.
-
Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.Hepatology. 2003 Jul;38(1):267. doi: 10.1053/jhep.2003.50213. Hepatology. 2003. PMID: 12830010 No abstract available.
-
[Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].Dtsch Med Wochenschr. 1999 May 21;124(20):636-42. doi: 10.1055/s-2007-1024379. Dtsch Med Wochenschr. 1999. PMID: 10370387 Review. German. No abstract available.